Companies buy stake in Ausnutria Dairy

AUSNUTRIA Dairy Corporation Ltd, a pediatric milk formula company with its production facilities principally based in China as well as in the Netherlands, said a Taiwan-listed company, Center Laboratories Inc., and Bioengine Capital Inc., a non-wholly-owned subsidiary of Center Lab, have conditionally agreed to purchase approximately 25.84% of the issued share capital of Ausnutria at a total consideration of approximately HKD 765.08 million, equivalent to HKD3.00 per share, which represents a premium of 12.36% over the closing price of the shares of HKD2.67 on Monday.

Based in Taipei City, Taiwan, Center Lab was founded in 1959 and listed on the GreTai Securities Market in Taiwan since 2003. With extensive experience in manufacturing and selling pharmaceutical products primarily in Taiwan, it offers a range of liquid oral drug products to infants, children, the elderly and special care patients. The company also carries out research and produce raw materials and high-end functional probiotic powder, which are applied in food, healthcare and pharmaceutical products. Bioengine engages in investment, biotechnology, research and development as well as intellectual property activities.

Upon the completion of the shares transfer, the original founding team of Ausnutria will be holding approximately 33.10% of the shares and remains as the major shareholder of the company.